Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 60,540 shares at $7.37 ($451K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Seasonal sale ($451k) by Executive VP, Global R&D — this insider has traded TEVA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.48 | 6,618 | $50K | 11.0% |
| 2 | $7.48 | 18,020 | $135K | 29.9% |
| 3 | $7.48 | 18,020 | $135K | 29.9% |
| 4 | $7.37 | 8,941 | $66K | 14.6% |
| 5 | $7.37 | 8,941 | $66K | 14.6% |
| Total | $7.45 avg | 60,540 |
| $451K |
| 100% |
| Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-08-12 | $1.0M | — | Filing → |
| TEVA | SELL | 2021-05-13 | $390K | — | Filing → |